Cite
HARVARD Citation
Oki, Y. et al. (n.d.). Prospective phase II study of rituximab with alternating cycles of hyper‐CVAD and high‐dose methotrexate with cytarabine for young patients with high‐risk diffuse large B‐cell lymphoma. British journal of haematology. pp. 611-620. [Online].